相关实验视频
Updated: Sep 13, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
对免疫检查点抑制剂的二次性心脏性休克的静脉动脉外体膜氧化支持
Quynh Nguyen1,2, Hossein Shayan1,3
1Division of Cardiac Surgery, University of British Columbia, Vancouver, BC, Canada.
特雷梅利马布/杜尔瓦卢马布治疗癌症的一个罕见但严重的副作用是发性心肌炎. 及时识别和高剂量的皮质类固醇导致一个患有晚期肝细胞癌的患者完全康复.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
背景情况:
- 免疫检查点抑制剂 (ICI),如特梅利马布/杜尔瓦马布,已经在癌症治疗中取得了进展,特别是在不可切除的肝细胞癌 (HCC) 中.
- 虽然有效,但ICI携带与免疫相关的不良事件的风险,包括潜在的致命性心肌炎.
研究的目的:
- 报告特雷梅利马布/杜尔瓦卢马布治疗HCC后爆发性心肌炎的病例.
- 突出早期识别和干预在管理ICI相关心肌炎中的关键作用.
主要方法:
- 一份病例报告显示,一名66岁的女性患有晚期HCC,接受了特雷梅利木巴/杜尔瓦木巴治疗.
- 临床表现,诊断结果和管理的描述,包括V-A ECMO和高剂量的皮质类固醇.
主要成果:
- 患者在开始STRIDE协议后38天出现了 fulminant心肌炎.
- 心脏性休克需要机械循环支持 (V-A ECMO).
- 高剂量皮质类固醇治疗导致心脏功能完全恢复.
结论:
- 虽然ICI相关心肌炎很少见 (1.14%的患病率),但可能导致严重的心脏事件.
- 及时诊断和积极的免疫抑制对于ICI诱导的心肌炎的良好结果至关重要.
- 临床医生必须在接受ICI治疗的患者中保持对心肌炎的高度怀疑指数.
更多相关视频
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Cardiomyopathy II: Dilated Cardiomyopathy
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Myocarditis III: Medical Management